| Literature DB >> 27793138 |
Li Guo1, Ying Feng2, Hong-Gang Guo3, Bo-Wen Liu4, Yang Zhang4.
Abstract
BACKGROUND: Malocclusion is a common disease of oral and maxillofacial region. The study was aimed to investigate levels changes of periodontal pathogens in malocclusion patients before, during and after orthodontic treatments, and to confirm the difference between adults and children.Entities:
Keywords: Fixed orthodontic appliances; Malocclusion; Orthodontic treatment; Pathogens
Mesh:
Year: 2016 PMID: 27793138 PMCID: PMC5084385 DOI: 10.1186/s12903-016-0308-7
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Primer sequences for P.gingivalis, F. nucleatum, P. intermedia and T. forsythensis
| Sequences | Amplified fragment length | |
|---|---|---|
|
| F: 5′-AGGCAGCTTGCCATACTGCG-3′ | 404 bp |
| R: 5′-ACTGTTAGCAACTACCGATGT-3′ | ||
|
| F: 5′-AGAGTTTGATCCTGGCTCAG-3′ | 408 bp |
| R: 5′-GTCATCGTGCACACAGAATTGCTG-3′ | ||
|
| F: 5′-CGTGGACCAAAGATTCATCGGTGGA-3′ | 259 bp |
| R: 5′-CCGCTTTACTCCCCAACAAA-3′ | ||
|
| F: 5′-GCGTATGTAACCTGCCCGCA-3′ | 641 bp |
| R: 5′-TGCTTCAGTGTCAGTTATACCT-3′ |
Note: P.gingivalis Porphyromonas gingivalis, F. nucleatum Fusobacterium nucleatum, P. intermedia Prevotella intermedia, T. forsythensis Tannerella forsythensis
The percentage contents and detective amount of the P.gingivalis, F. nucleatum, P. intermedia and T. forsythensis in adults and adolescents
| Baseline | One month after treatment | Three months after treatment | ||||
|---|---|---|---|---|---|---|
| Percentage contents | Detective amount (log10) | Percentage contents | Detective amount (log10) | Percentage contents | Detective amount (log10) | |
|
| ||||||
| Adults | 0.090 ± 0.047* | 6.30 | 0.392 ± 0.621* | 6.26 | 0.451 ± 0.545 | 6.20 |
| Adolescents | 0.005 ± 0.013 | 6.27 | 0.072 ± 0.064 | 6.23 | 0.278 ± 0.780 | 6.18 |
| Total | 0.025 ± 0.121 | 0.195 ± 0.650 | 0.347 ± 0.812# | |||
|
| ||||||
| Adults | 0.083 ± 0.149* | 6.34 | 0.387 ± 0.578 | 6.26 | 0.433 ± 0.479 | 6.11 |
| Adolescents | 0.012 ± 0.028 | 6.32 | 0.082 ± 0.066 | 6.26 | 0.317 ± 0.472 | 6.23 |
| Total | 0.033 ± 0.074 | 0.167 ± 0.356 | 0.401 ± 0.611# | |||
|
| ||||||
| Adults | 0.093 ± 0.148* | 6.36 | 0.402 ± 0.431* | 6.23 | 0.413 ± 0.512 | 6.15 |
| Adolescents | 0.010 ± 0.047 | 6.30 | 0.087 ± 0.079 | 6.20 | 0.255 ± 0.526 | 6.18 |
| Total | 0.030 ± 0.065 | 0.188 ± 0.518 | 0.349 ± 0.714# | |||
|
| ||||||
| Adults | 0.081 ± 0.061* | 6.30 | 0.394 ± 0.572* | 6.18 | 0.488 ± 0.509* | 6.08 |
| Adolescents | 0.009 ± 0.027 | 6.27 | 0.091 ± 0.107 | 6.15 | 0.284 ± 0.305 | 6.04 |
| Total | 0.036 ± 0.101 | 0.145 ± 0.416 | 0.373 ± 0.717# | |||
Note: *, compared with the percentage of adolescents, P < 0.05; #, compared with the percentage at baseline, P < 0.05
Detection results of clinical indicators, PLI, SBI and PD, in adults and adolescents
| Baseline | One month after treatment | Three month after treatment | |
|---|---|---|---|
| PLI | |||
| Adults | 0.195 ± 0.311a | 0.610 ± 0.512* | 0.780 ± 0.531* |
| Adolescents | 0.491 ± 0.367 | 0.637 ± 0.444* | 0.899 ± 0.490* |
| Total | 0.345 ± 0.292 | 0.680 ± 0.463* | 0.876 ± 0.462* |
| SBI | |||
| Adults | 0.253 ± 0.412 | 1.123 ± 0.503* | 1.119 ± 0.148* |
| Adolescents | 0.278 ± 0.457 | 0.993 ± 0.492* | 1.002 ± 0.481* |
| Total | 0.283 ± 0.505 | 0.976 ± 0.0.484* | 0.984 ± 0.0.496*,# |
| PD | |||
| Adults | 0.056 ± 0.122a | 1.188 ± 0.164* | 1.047 ± 0.148* |
| Adolescents | 1.015 ± 0.101 | 1.190 ± 0.172* | 1.021 ± 0.104* |
| Total | 1.020 ± 0.103 | 1.178 ± 0.180 | 1.100 ± 0.0.142*,# |
PLI plaque index, SBI sulcus bleeding index, PD probing depth
Note: *, compared with the index level at baseline, P < 0.05; #, compared with the index level one month after treatment, P < 0.05
acompared with the index level of the adolescents at baseline